Target intelligence / Profile preview

Alpha-amylase (α-Amylase)

Target
α-Amylase
Molecular classification
Enzyme, Glycoside hydrolase family 13 (GH13), Metalloenzyme (calcium-dependent)
01

Overview

Alpha-amylase is a calcium-dependent enzyme that catalyzes the endohydrolysis of internal α-(1→4) glycosidic bonds in starches and related polysaccharides, producing smaller sugars like maltose and dextrins. It is widely distributed across animals (notably humans), plants, fungi, and bacteria. In humans, two main forms exist—salivary alpha-amylase initiates starch digestion in the mouth while pancreatic alpha-amylase continues this process in the small intestine. Structurally, it features a characteristic three-domain architecture with an eight-stranded α/β barrel catalytic domain containing key acidic residues at its active site; calcium ions stabilize its structure. Alpha-amylases are essential for energy metabolism from complex carbohydrates and have major industrial applications including food processing and biotechnology. Clinically relevant inhibitors are used to manage type 2 diabetes by slowing carbohydrate absorption from food.

Other names
1,4-α-D-glucan glucanohydrolaseGlycogenaseSalivary amylase (for the salivary isoform)Pancreatic amylase (for the pancreatic isoform)EC 3.2.1.1
02

Mechanism of action

Drugs such as acarbose inhibit alpha-amylase by binding to its active site, thereby blocking the hydrolysis of dietary starch into absorbable sugars and reducing postprandial blood glucose spikes.

03

Biological functions

Hydrolysis of starch and glycogen to oligosaccharides and disaccharidesDigestion of dietary carbohydratesInitial step in carbohydrate metabolism in animals, plants, and microorganisms
04

Disease associations

Diabetes mellitus (as a biomarker for pancreatic function)Acute pancreatitis (diagnostic marker)Obesity/metabolic syndrome research target
05

Safety considerations

Inhibition can cause gastrointestinal side effects such as flatulence, diarrhea, or abdominal discomfort due to undigested carbohydrates reaching the colon.Overactivity or leakage into blood can indicate tissue damage or disease but is not itself directly toxic.
06

Interacting drugs

Acarbose

1 more in the full profile.

Beyond the preview

Go deeper on Alpha-amylase (α-Amylase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alpha-amylase (α-Amylase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call